NASDAQ · Medical - Devices

Lumexa Imaging Holdings, Inc. (LMRI) Stock

$10.54 +2.03% NASDAQ: LMRI Healthcare

Valuation

MetricValue
Price$10.54
Market Cap$1.01B
P/E Ratio-30.22
P/B Ratio1.77
P/S Ratio1.05
EPS (TTM)$-0.66
52-Week High$19.45
52-Week Low$6.45
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-5.64%
ROA-1.53%
ROCE0.88%
Gross Margin11.65%
Operating Margin1.12%
Net Margin-2.66%
Debt/Equity1.59
Current Ratio1.44

Annual Financials (USD)

Metric202320242025
Revenue$936.0M$949.0M$1.0B
Operating Profit$22.0M$55.0M$27.0M
Net Profit$-122.0M$-94.0M$-47.0M
EPS$-1.29$-1.00$-0.66
Op Margin2.4%5.8%2.6%

Balance Sheet (USD)

Metric202320242025
Total Assets$1.7B$1.7B$1.8B
Total Liabilities$1.5B$1.5B$1.2B
Cash$20.0M$26.0M$59.0M
Borrowings$1.3B$1.3B$963.0M

Latest News

Zacks Industry Outlook Highlights Terumo, QuidelOrtho, Lumexa Imaging and Brainsway Zacks · Jul 21, 2026 Wall Street Analysts Think Lumexa (LMRI) Could Surge 44.08%: Read This Before Placing a Bet Zacks · Jul 13, 2026 UG Outperforms Industry in 6 Months: Buy, Sell or Hold the Stock? Zacks · Jul 8, 2026 Lumexa Imaging Refinances Debt MT Newswires · Jul 1, 2026 Wall Street Analysts Believe Lumexa (LMRI) Could Rally 73.25%: Here's is How to Trade Zacks · Jun 25, 2026

Cash Flow (USD)

Metric202320242025
Operating Cash Flow$38.0M$41.0M$17.0M
Investing Cash Flow$-54.0M$-50.0M$-44.0M
Financing Cash Flow$0$-1.0M$2.0M
Net Cash Flow$-1.0M$6.0M$33.0M
Free Cash Flow$14.0M$13.0M$-6.0M

Valuation & Return Ratios

MetricValue
PEG Ratio2.19
EV / EBITDA17.92
FCF Yield2.92%
Quick Ratio1.44
Interest Coverage0.16
Return 1Y—
Return 3Y—
Return 5Y—

Ownership

Insiders Held80.79%
Institutions Held34.61%
Institutions Float Held180.11%
Institutional HolderSharesReport Date
Alliancebernstein L.P.2,980,4622026-03-31
Massachusetts Financial Services Co.2,334,5802026-03-31
Janus Henderson Group PLC2,100,3562026-03-31
Brown Advisory Inc.1,705,0772026-03-31
ArrowMark Colorado Holdings LLC1,653,2582026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CCMConcord Medical Services Holdings Limited $4.32 +7.20% -0.03 $629052 0.00%
RDNTRadNet, Inc. $70.91 +3.96% -265.10 $5.58B 0.00%

About Lumexa Imaging Holdings, Inc.

Lumexa Imaging Holdings, Inc. is led by CEO Caitlin Zulla, headquartered in US, publicly traded since 2025.

Lumexa Imaging Holdings, Inc. (LMRI) stock trades at $10.54 with a market capitalization of $1.01B. The stock is valued at a price-to-earnings (P/E) ratio of -30.22, price-to-book of 1.77, price-to-sales of 1.05. Over the past 52 weeks the stock has ranged between $6.45 and $19.45, and currently trades 45.8% below its 52-week high.

On profitability, Lumexa Imaging Holdings, Inc. generates a return on equity (ROE) of -5.64%, return on capital employed of 0.88%, an operating margin of 1.12%, a net profit margin of -2.66%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides